A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Clinical trial NCT07174336 · RECRUITING
Trial details
- NCT number
- NCT07174336
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-22
- Primary completion
- 2029-05-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.